The purpose of this study is to assess the feasibility of a randomized, double-blind, placebo-controlled pilot trial evaluating the effect of tropisetron on prevention of postoperative cognitive dysfunction in patients after cardiac surgery.
Postoperative cognitive dysfunction is a common complication during postoperative period,especially in elderly patients. It is characterized by cognitive decline, inattention and abnormal mental status following surgery. The presence of postoperative cognitive dysfunction is independently associated with poor recovery, increased hospital length of stay and increased mortality. Tropisetron is a 5-HT3A receptor antagonist and is widely used to treat postoperative nausea and vomiting. Previous studies found that tropisetron has positive effect on cognitive function. We have designed a randomized, double-blind, placebo-controlled trial to determine if tropisetron has a positive effect on postoperative coginitive function in patients after cardiac surgery. Several assessements which are related to delirium, cognitive function, sleep and functional status, blood sample collection and EEG recordings will be involved in the trial. Moreover, we have assumed a few long-term follow-ups. Given the complexity of the trial, we have decided to implement a pilot trial to assess the feasibility and provide vital data for future formal trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
72
Investigators administrated intravenously Tropisetron 5mg before anesthesia and once daily for 7 days after surgery.
Investigators administrated intravenously saline solution as a placebo
Beijing Chaoyang Hospital, Capital Medical University
Beijing, China
RECRUITINGThe feasibility of tropisetron intervention on POCD in patients after cardiac surgery
The feasibility will mainly be determined by the percentage of participants who completed the whole study procedure from recruitment to the 1-month follow-up.
Time frame: Within 30 days after surgery
Incidence of postoperative cognitive dysfunction
Screening of the patients regarding a POCD by Repeatable Battery Neuropsychological Status (RBANS). Besides, the changes in SCWT and IRI scores will be an additional indication of POCD.
Time frame: One day before surgery, discharge from hospital and 1 month after surgery
Incidence of postoperative delirium
Screening of the patients regarding a postoperative delirium by The Confusion Assessment Method for The Intensive Care Unit (CAM-ICU)
Time frame: Within 7 days after surgery
Functional status measurement
Screening of the patients by Barthel Index scale ranging from 0 to 100, where less than 20 indicates total dependence, 20-35 scores indicate severe dependence, 40-55 scores indicate moderate dependence, equal or over 60 indicates mild dependency and 100 indicates independence.
Time frame: One day before surgery and 1 month after surgery
EEG frequency spectrum
Electroencephalography will be recorded at different points of time as follows and EEG characteristics including power in alpha, beta, theta, delta, gamma, spectrum will be extracted using MATLAB: 1. before anesthesia introduction 2. during anesthesia 3. 1 day after surgery 4. 2 days after surgery 5. 3 days after surgery
Time frame: Within 3 days after surgery
Postoperative Pain
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Visual Analogue Scale will be used to assess postoperative pain of patients. Numerical rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain.
Time frame: Within 7 days after surgery
Sleep Quality
Sleep diary and subjective sleep quality scores(Visual Analogue Scale) will be used to assess postoperative sleep quality of patients within 7 days after surgery. Chinese version of the Pittsburgh sleep quality index (PSQI) will be used to assess sleep quality and disturbances. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score. The total score is between 0 and 21. The total score ≤ 5 indicates good sleep quality,\> 5 indicates poor sleep quality. PSQI will be recorded at different points of time as follows: 1. 1 day before surgery 2. 30 days after surgery
Time frame: Within 30 days after surgery
Incidence of postoperative nausea and vomiting
Time frame: Within 7 days after surgery
Length of ICU stay
Time frame: From the date of admission until discharged from ICU, up to 30 days
Length of Hospital stay
Time frame: From the date of admission until discharged from hospital, up to 30 days
Incidence of major adverse cardiac and cerebral events
MACCE comprises all-cause mortality, myocardial infarction, repeat unplanned revascularization (surgical revision or percutaneous transluminal coronary angioplasty), and stroke
Time frame: Within 30 days after surgery
Inflammatory biomarkers
lood samples will be collected at different points of time as follows: 1. before anesthesia introduction 2. 1 day after surgery 3. 3 days after surgery 4. 7 days after surgery Levels of serum biomarkers, including but not limited to, interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor (TNF)α, Interferon (IFN)γ, Tau, vascular endothelial growth factor (VEGF)D and brain-derived neurotrophic factor (BDNF) will be examined using these specimens
Time frame: Within 7 days after surgery